MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
PBH — Prestige Consumer Healthcare Inc.
NYSEPrestige Consumer Healthcare Inc.
$47.57
+1.13(+2.43%)
- O
- 46.57
- H
- 47.72
- L
- 46.34
- V
- 460.85K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About PBH
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 10, 2005
Employees890
Stock ExchangeNYSE
Ticker SymbolPBH
Key Financial Statistics
| Market Cap | $2.14B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $42.62 - $71.07 |
| 52-Week Avg Volume | 531.4K |
| VWAP | $47.30 |
| Transactions | 10,647 |
| Total Recorded Bars | 5,447 days |